+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 15Years - 18Years
All Genders
ID06951074

Stem Cell Therapy Using Insulin-Producing Mesenchymal Stem Cells for Youth with Type 1 Diabetes

Led by Ain Shams University · Updated on 2025-04-30

20

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Type 1 Diabetes is a chronic autoimmune condition caused by the destruction of pancreatic Beta cells, leading to a total lack of insulin. Researchers are studying the use of stem cells derived from adipose tissue mesenchymal origin to develop insulin-producing cells as a potential new treatment. This study evaluates autologous insulin-producing mesenchymal stem cells in youth with type 1 diabetes, aiming to improve blood sugar control and reduce dependence on standard treatments. The trial involves collecting fat tissue from participants through liposuction, then isolating and differentiating mesenchymal stem cells into insulin-producing cells in the lab. Participants receive these cells by injection either into the portal vein or into the peripheral bloodstream. The study compares these two delivery methods and monitors the ability of these cells to produce insulin both in the lab and in the body over one year. Participants will undergo assessments including lab tests to measure insulin and C-peptide release in response to glucose. Researchers will track blood sugar control after the transplant and follow participants for one year to evaluate the effectiveness and safety of the treatment. The study lasts for one year after transplantation, with ongoing monitoring to understand the benefits and risks of this innovative therapy.

CONDITIONS

Brief Title

Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes

Research Team

R

Rasha S Elmetwally, MD

R

Rasha S Eladawy, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here